Results 91 to 100 of about 125,028 (162)

Oral Anticoagulant Therapy of Patients With Atrial Fibrillation in Cardiology, Internal Medicine, and Surgery: Temporal Trend. [PDF]

MedComm (2020)
Lin M, Huang H, Wang J, Sun H, Xu X, Zhang Y, Han W, Chen M, Dong K, Wang Y, You B, Yao G, Zhong J, Huang C.   +13 more
europepmc   +1 more source

Oral anticoagulant therapy and outcomes in new-onset atrial fibrillation during acute myocardial infarction: A systematic review and meta-analysis. [PDF]

World J Cardiol
Pereverzeva KG, Glenza A, Yakushin SS.
europepmc   +1 more source

Gross haematuria in the era of anticoagulant therapy - Implications on treatment and diagnostic approaches in a large emergency department patient population. [PDF]

BJUI Compass
Yang Y, Seidl J, Engelmann SU, Haas M, Mayr R, Burger M, Breyer J, Resch M.   +7 more
europepmc   +1 more source

Risk of amyloid-related imaging abnormalities associated with anticoagulant therapy in patients with Alzheimer's disease treated with anti-amyloid monoclonal antibodies: a systematic review and meta-analysis. [PDF]

J Neurol Neurosurg Psychiatry
Schlemm E, Gauthier S, Magnus T, Thomalla G, Rosa-Neto P, Woo MS.   +5 more
europepmc   +1 more source

Association of Peptic Ulcer Disease and Gastrointestinal Hemorrhage With Long-Term Use of Antiplatelet and Anticoagulant Therapy in Patients With Ischemic Heart Disease. [PDF]

Cureus
Jain K, Shaikh M, Butt AS, Mansha MM, Madathiparambu NC, Rizwan A, Younas S, Khan MAZ.   +7 more
europepmc   +1 more source

Anticoagulant Therapy in Neonatal Acute Infectious Peritonitis Based on the TAT, PIC, t-PAIC, and sTM: A New Case Series. [PDF]

TH Open
Wang W, Gao Y, Qiao Y, Wu Y, Li J, Zhang L.   +5 more
europepmc   +1 more source

Correction: Anticoagulant therapy and altered tissue factor expression protect against experimental placental and cerebral malaria. [PDF]

PLoS Pathog
Andrew AK, Bracken TC, Nazario-Maldonado N, Russ BN, Gonzalvo KT, Brainard BM, Mackman N, Moore JM.   +7 more
europepmc   +1 more source

Decision-making regarding anticoagulant therapy in the last phase of life: In-depth interview study with healthcare professionals (the OPTIMA trial). [PDF]

Palliat Med
van Hylckama Vlieg MAM, de Beukelaar KJI, Spreeuw RHL, Kruip MJHA, Kuy PHMV, Heide AV, van der Rijt CCD, Geijteman ECT.   +7 more
europepmc   +1 more source

Real-world clinical decision of andexanet alfa administration for intracranial hemorrhage during anticoagulant therapy using factor Xa inhibitor. [PDF]

J Crit Care Med (Targu Mures)
Yamashiro S, Harada K, Izumi S, Morikawa Y, Ikemoto T, Kameno K, Goto T, Ohmori Y, Kaji M, Mukasa A.   +9 more
europepmc   +1 more source